NanoString Technologies, Inc. NSTG released a preliminary update of the second quarter, where revenues are expected to be over $44 million, representing year-on-year growth of approximately 37%. The ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min It's the second round of layoffs ...
Products Represent the Highest Plex In Situ Imager and the First Cloud-Based Data Analysis Suite for Spatial Biology SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading ...
NanoString Technologies Inc (NASDAQ:NSTG) shares are trading lower after a jury in the U.S. District Court for the District of Delaware reached a unanimous verdict favoring 10x Genomics Inc ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Research device company ...
NanoString is an Established Leader and Valuable Innovator in Gene Expression Profiling and Spatial Transcriptomics for Scientific and Clinical Research in Healthcare Under the asset purchase ...
NanoString Technologies (OTC:NSTGQ) has signed an agreement with Patient Square Capital, a leading healthcare investment firm, to acquire the majority of NanoString’s global business assets for a sum ...
A little more than two months ago, NanoString Technologies filed for bankruptcy – weary from having to pay $31 million to 10X Genomics after losing a patent infringement lawsuit. Today is a different ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback